Arzeda and Mitsubishi Rayon in Synthetic Biology Project

US synthetic biology company Arzeda and Japan’s Mitsubishi Rayon are collaborating to develop an improved process for producing a chemical building block with multiple applications.

The partnership will leverage each company’s unique technologies. Arzeda will use its proprietary industrial protein design software, Archytas, while Mitsubishi Rayon will apply its expertise in process development and industrial scale-up.

Arzeda’s proprietary platform can rapidly create “cell factories” to create new enzymes and chemical products that can be used at industrial scale. Since 2008, it has developed a range of enzymes and specialty chemicals for polymers, advanced materials, and health and nutrition products.

Alexandre Zanghellini, CEO of Arzeda, said that through synthetic biology, the company can unlock new opportunities for innovative, high-performing and sustainable products.

Takayuki Iseki, general manager of Mitsubishi Rayon’s R&D Administration department, added: “Through our own experience and expertise, as well as with innovative technology like Arzeda’s, Mitsubishi Rayon can meet the growing global demand for a range of products in a sustainable manner.”

Mitsubishi Rayon is a major supplier of methyl methacrylate (MMA) monomer, as well as hollow fiber membranes, carbon fiber, plastic optical fiber, and other products.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.